66 related articles for article (PubMed ID: 8677455)
1. Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony-Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation.
Chen W; Boras B; Sung T; Hu W; Spilker ME; D'Argenio DZ
AAPS J; 2020 Nov; 22(6):143. PubMed ID: 33156437
[TBL] [Abstract][Full Text] [Related]
2. A whole-body circulatory neutrophil model with application to predicting clinical neutropenia from in vitro studies.
Chen W; Boras B; Sung T; Hu W; Spilker ME; D'Argenio DZ
CPT Pharmacometrics Syst Pharmacol; 2021 Jul; 10(7):671-683. PubMed ID: 33793091
[TBL] [Abstract][Full Text] [Related]
3. Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies.
Hamberg P; Steeghs N; Loos WJ; van de Biessen D; den Hollander M; Tascilar M; Verweij J; Gelderblom H; Sleijfer S
Br J Cancer; 2010 Jun; 102(12):1699-706. PubMed ID: 20485286
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Blasts in a Patient Receiving Chemotherapy.
Kshattry S; Parker TL; Huntington SF
JAMA; 2023 Oct; 330(16):1581-1582. PubMed ID: 37801303
[TBL] [Abstract][Full Text] [Related]
5. Renal toxicity of ifosfamide in children with cancer: an exploratory study integrating aldehyde dehydrogenase enzymatic activity data and a wide-array urinary metabolomics approach.
Febvey-Combes O; Guitton J; Marec-Berard P; Faure-Conter C; Blanc E; Chabaud S; Conjard-Duplany A; Schell M; Derain Dubourg L
BMC Pediatr; 2024 Mar; 24(1):196. PubMed ID: 38504218
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy Primary Dose Reduction in Older Cancer Patients: A Retrospective Cohort.
Bouleftour W; Tinquaut F; Lafaie L
Cancer Invest; 2024 May; 42(5):416-424. PubMed ID: 38785096
[TBL] [Abstract][Full Text] [Related]
7. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Crawford J; George M
Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-108-S2-112. PubMed ID: 9045327
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
12. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer.
Belani CP; Aisner J; Hiponia D; Engstrom C
Semin Oncol; 1995 Aug; 22(4 Suppl 9):7-12. PubMed ID: 7544028
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
